Price $378.08 |
Market Cap
16.86B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
64.3
|
P/B
11.1
|
P/S
15.87
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
68.6
|
Op. Cash Flow
285.4K
|
FCF
5.4
|
|
Op. Margin
13.10%
|
Net Margin
12.70%
|
ROE
9.30%
|
ROI
5.80%
|
|
ROA
8.40%
|
EPS Growth
-12.30%
|
Current Ratio
7.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $2.41 | - | - | 105.8M | Strong Buy |
| Cytosorbents Corp (CTSO) | $1.51 | - | - | 71.5M | Strong Buy |
| One World Products Inc (OWPC) | $0.09 | - | - | 5.6M | Strong Buy |
| Endexx Corp (EDXC) | $0.06 | - | - | 34.8M | Strong Buy |
| Akumin Inc (AKU) | $1.04 | - | - | 135.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
